Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-like 1

Journal of Immunology

Volumn 176, Issue 5, 2006, Pages 2969-2975

  Kim, Youndong ^a   Lee, Byoung Dae ^a   Kim, Oekyung ^a   Bae, Yoe Sik ^b   Lee, Taehoon ^c   Suh, Pann Ghill ^a   Ryu, Sung Ho ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Dong A University   (South Korea)

^c Sigmol Incorporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPEPTIDE; PEPTIDE; TRYPTOPHYLARGINYLTRYPTOPHYLTRYPTOPHYLTRYPTOPHYLTRYPTOPHAN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; BASOPHIL; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 33644518230     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.5.2969     Document Type: Article

References (34)

1. Hoyle, C. H. 1998. Neuropeptide families: evolutionary perspectives. Regul Pept. 73: 1-33.
2. Sherwood, N. M., S. L. Krueckl, and J. E. McRory. 2000. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagons superfamily. Endocr. Rev. 21: 619-670.
3. Martinez, C. M., M. Delgado, D. Pozo, J. Leceta, J. R. Calvo, D. Ganea, and R. P. Gomariz. 1998. Vasoactive intestinal peptide and pituitary adenlyate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages. J. Leukocyte Biol. 63: 591-601.
4. Martinez, C., M. Delgado, D. Pozo, J. Leceta, J. R. Calvo, D. Ganea, and R. P. Gomariz. 1998. VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studies. J. Neuroimmunol. 85: 155-167.
5. Gottschall, P. E., I. Tatsuno, and A. Arimura. 1994. Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res. 637: 197-203.
6. Delgado, M., J. Leceta, and D. Ganea. 2003. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia. J. Leukocyte Biol. 73: 155-164.
7. Delgado, M., C. Martinez, D. Pozo, J. R. Calvo, J. Laceta, D. Ganea, and R. P. Gomariz. 1999. Vasoactive intestinal peptide (VIP) and pituitary adenlyate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6. J. Immunol. 162: 1200-1205.
8. Delgado, M., and D. Ganea. 1999. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor κB and Ets activation. J. Biol. Chem. 274: 31930-31940.
9. Sheward, W. J., E. M. Lutz, A. J. Copp, and A. J. Harmar. 1998. Expression of PACAP, and PACAP type 1 (PAC1) receptor mRNA during development of the mouse embryo. Brain Res. Dev. Brain Res. 109: 245-253.
10. Couvineau, A., C. Rouyer-Fessard, D. Darmoul, J. J. Maoret, I. Carrero, E. Ogier-Denis, and M. Laburthe. 1994. Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem. Biophys. Res. Commun. 200: 769-776.
11. Laburthe, M., A. Couvineau, P. Gaudin, J. J. Maoret, C. Rouyer-Fessard, and P. Nicole. 1996. Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors: structure-function relationship with special reference to the human VIP-1 receptor. Ann. NY Acad. Sci. 805: 94-109.
12. Schafer, H., J. Zheng, C. Morys-Wortmann, U. R. Folsch, and W. E. Schmidt. 1999. Structural motifs of pituitary adenylate cyclase-activating polypeptide (PACAP) defining PAC1-receptor selectivity. Regul Pept. 79: 83-92.
13. Bae, Y. S., H. Bae, Y. Kim, T. G. Lee, P. G. Suh, and S. H. Ryu. 2001. Identification of novel chemoattractant peptides for human leukocytes. Blood 97: 2854-2862.
14. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
15. Harfi, I., S. D'Hondt, F. Corazza, and E. Sariban. 2004. Regulation of human polymorphonudear leukocytes functions by the neuropeptide pituitary adenylate cyclase-activating polypeptide after activation of MAPKs. J. Immunol. 173: 4154-4163.
16. Bae, Y. S., H. Y. Lee, E. J. Jo, J. I. Kim, H. K. Kang, R. D. Ye, J. Y. Kwak, and S. H. Ryu. 2004. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 173: 607-614.
17. Le, Y., W. Gong, B. Li, N. M. Dunlop, W. Shen, S.B. Su, R. D. Ye, and J. M. Wang. 1999. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J. Immunol. 163: 6777-6784.
18. Inooka, H., T. Ohtaki, O. Kitahara, T. Ikegami, S. Endo, C. Kitada, K. Ogi, H. Onda, M. Fujino, and M. Shirakawa. 2001. Conformation of peptide ligand bound to its G-protein coupled receptor. Nat. Struct. Biol. 8: 161-165.
19. 125I]-PACAP27. Neurosci. Lett. 338: 155-158.
20. 2+. Biochem. J. 374: 281-296.
21. Le, Y., P. M. Murphy, and J. M. Wang. 2002. Formyl-peptide receptors revisited. Trends Immonol. 23: 541-548.
22. Garrido, E., M. Delgado, C. Martinez, R. P. Gomariz, and M. De la Fuente. 1996. Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility. Neuropeptides 30: 583-595.
23. Delgado, M., M. De la Fuente, C. Martinez, and R. P. Gomariz. 1995. Pituitary adenylate cyclase-activating polypeptide (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP. J. Neuroimmunol. 62: 137-146.
24. Kinhult, J., R. Uddman, M. Laan, A. Linden, and L. O. Cardell. 2001. Pituitary adenlyate cyclase-activating peptide inhibits neutrophil chemotaxis. Peptides 22: 2151-2154.
25. Hegg, C. C., E. Au, A. J. Roskams, and M. T. Lucero. 2003. PACAP is present in the olfactory system and evokes calcium transients in olfactory receptor neurons. J. Neurophysiol. 90: 2711-2719.
26. Nagakura, T., T. Onda, Y. Iikura, T. Masaki, H. Nagakura, and T. Endo. 1989. High molecular weight-neutrophil chemotactic activity in nasal allergy. Allergy Proc. 10: 233-235.
27. Cox, H. M. 1992. Pituitary adenylate cyclase activating polypeptides. PACAP27 and PACAP38: stimulators of electrogenic ion secretion in the rat small intestine. Br. J. Pharmacol. 106: 498-502.
28. Ekblad, E., and F. Sundler. 1997. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle. Eur. J. Pharmacol. 334: 61-66.
29. Keitoku, M., M. Kohzuki, H. Katoh, M. Funakoshi, S. Suzuki, M. Takeuchi, A. Karibe, S. Horiguchi, J. Watanabe, S. Satoh, et al. 1997. FMLP actions and its binding sites in isolated human coronary arteries. J. Mol. Cell Cardiol 29: 881-894.
30. Kristiansen, K. 2004. Molecular mechanism of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol. Ther. 103: 21-81.
31. Rosen, H., and J. Liao. 2003. Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigm. Curr. Opin. Chem. Biol. 7: 461-468.
32. Kostenis, E. 2004. A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands. Pharmacol. Ther. 102: 243-257.
33. Waldhoer, M., S. E. Bartlett, and J. L. Whistler. 2004. Opioid receptors. Ann. Rev. Biochem. 73: 953-990.
34. Murphy, P. M., T. Ozcelik, R. T. Kenney, H. L. Tiffany, D. McDermott, and U. Francke. 1992. A structural homologue of the N-formyl peptide receptor: characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267: 7637-7643.